About Cerulean Pharma
Cerulean Pharma is a company based in Cambridge (United States) founded in 2006 was acquired by Daré Bioscience in March 2017.. Cerulean Pharma has raised $88.7 million across 11 funding rounds from investors including ARE, Bessemer Venture Partners and Daré Bioscience. The company has 20 employees as of December 31, 2016. Cerulean Pharma offers products and services including Prescription Medications, Over-the-Counter Drugs, and Generic Drugs. Cerulean Pharma operates in a competitive market with competitors including Jazz Pharmaceuticals, Moderna, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter Cambridge, United States
- Employees 20 as on 31 Dec, 2016
- Stage Public
-
Sectors
TechnologyHealthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cerulean Pharma Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$88.7 M (USD)
in 11 rounds
-
Latest Funding Round
-
Investors
ARE
& 7 more
-
Employee Count
20
as on Dec 31, 2016
-
Acquired by
Daré Bioscience
(Mar 19, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cerulean Pharma
Cerulean Pharma offers a comprehensive portfolio of products and services, including Prescription Medications, Over-the-Counter Drugs, and Generic Drugs. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for ordering and delivering regulated prescription drugs securely.
Sale of non-prescription items like vitamins and analgesics for daily use.
Lower-cost alternatives to brand drugs for various health conditions.
Funding Insights of Cerulean Pharma
Cerulean Pharma has successfully raised a total of $88.7M across 11 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 11
- Last Round Last Round
-
First Round
First Round
(22 Mar 2007)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2016 | Amount | Post-IPO - Cerulean Pharma | Valuation |
investors |
|
| Apr, 2015 | Amount | Post-IPO - Cerulean Pharma | Valuation |
investors |
|
| Jan, 2015 | Amount | Debt – Venture - Cerulean Pharma | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cerulean Pharma
Cerulean Pharma has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include ARE, Bessemer Venture Partners and Daré Bioscience. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture debt financing is provided to companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital investments and support for entrepreneurs in technology and innovation sectors.
|
Founded Year | Domain | Location | |
|
Early-stage life sciences investments are targeted in the healthcare sector.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cerulean Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cerulean Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cerulean Pharma Comparisons
Competitors of Cerulean Pharma
Cerulean Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Moderna, BeiGene, Advanced Accelerator Applications and Incyte, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cerulean Pharma
Frequently Asked Questions about Cerulean Pharma
When was Cerulean Pharma founded?
Cerulean Pharma was founded in 2006 and raised its 1st funding round 1 year after it was founded.
Where is Cerulean Pharma located?
Cerulean Pharma is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Is Cerulean Pharma a funded company?
Cerulean Pharma is a funded company, having raised a total of $88.7M across 11 funding rounds to date. The company's 1st funding round was a Debt – Venture of $26M, raised on Mar 22, 2007.
How many employees does Cerulean Pharma have?
As of Dec 31, 2016, the latest employee count at Cerulean Pharma is 20.
What does Cerulean Pharma do?
Cerulean Pharma, formerly Tempo Pharmaceuticals, is a privately-held biopharmaceutical company focused on the development of novel nanotechnology-based therapeutics in the areas of oncology, cardiovascular, autoimmune and inflammatory diseases. The company has a Dynamic Tumor Targeting Platform to create a portfolio of nanoparticle-drug conjugates, or NDCs, designed to selectively attack tumor cells, reduce toxicity by sparing the bodys normal cells, and enable therapeutic combinations.Their lead product candidate, CRLX101, is in multiple clinical trials with other cancer treatments as part of a combination therapy.
Who are the top competitors of Cerulean Pharma?
Cerulean Pharma's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
What products or services does Cerulean Pharma offer?
Cerulean Pharma offers Prescription Medications, Over-the-Counter Drugs, and Generic Drugs.
Who are Cerulean Pharma's investors?
Cerulean Pharma has 8 investors. Key investors include ARE, Bessemer Venture Partners, Daré Bioscience, Hercules Capital, and Lilly Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.